Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Therapy

Unexplained infertility — ongoing transatlantic debate

A recent US study comparing different drugs for ovarian stimulation in women with unexplained infertility demonstrates that letrozole is less effective than gonadotropins or clomiphene; however, the primary end point for the study was not efficacy but, rather, multiple pregnancy rates. This study confirms, yet again, that gonadotropins are associated with unacceptably high rates of multiple births.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Legro, R. S. et al. Letrozole or clomiphene for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 371, 146–1464 (2014).

    Article  Google Scholar 

  2. Fauser, B. C. Revisiting ovulation induction in PCOS. Nat. Rev. Endocrinol. 10, 704–705 (2014).

    Article  CAS  PubMed  Google Scholar 

  3. Diamond, M. P. et al. Letrozole, gonadotropins, or clomiphene for unexplained infertility. N. Engl. J. Med. 373, 1230–1240 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Fauser, B. C. in Yen & Jaffe's Reproductive Endocrinology (eds Strauss, J. F. & Barbieri, R. L) 701–733 (Elsevier, 2014).

    Book  Google Scholar 

  5. Fauser, B. C. & Macklon, N. S. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 365, 1807–1816 (2005).

    Article  PubMed  Google Scholar 

  6. Bensdorp, A. J. et al. Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation. BMJ 350, g7771 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Evers, J. L. Female subfertility. Lancet 360, 151–159 (2002).

    Article  PubMed  Google Scholar 

  8. Kamphuis, E. I., Bhattacharya, S., van der Veen, F., Mol, B. W. & Templeton, A. Are we overusing IVF? BMJ 348, g252 (2014).

    Article  PubMed  Google Scholar 

  9. Steures, P. et al. Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial. Lancet 368, 216–221 (2006).

    Article  PubMed  Google Scholar 

  10. Reindollar, R. H. et al. Randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment trial. Fertil. Steril. 94, 888–899 (2010).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bart C. J. M. Fauser.

Ethics declarations

Competing interests

B.C.J.M.F. has received fees and grant support from COGI, Euroscreen, Ferring, Gedeon Richter, Finox, GenOvum, Nederlandse Hartstichting, NGI, Merck Serono, Pantarhei Bioscience, Preglem, Watson Laboratories and ZonMW.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fauser, B. Unexplained infertility — ongoing transatlantic debate. Nat Rev Endocrinol 12, 8–10 (2016). https://doi.org/10.1038/nrendo.2015.200

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2015.200

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing